Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Multiple Sclerosis Patient Response to COVID-19 Outbreak
Multiple Sclerosis (MS) Patient Response to COVID-19 Outbreak: Recruiting Participants with and without MS
Sponsor:Columbia University
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAS9668
Contact: Fatoumata Diallo: 212-305-1485 /
Additional Study Information:

We need your help today to gather information about the experience of multiple sclerosis (MS) patients and the general population during the COVID-19 pandemic. Most MS patients take one of over a dozen of medications to control their disease, and these medications alter the immune system. These effects are not as strong as those experienced by patients with organ transplants or cancer patients on chemotherapy; however, we do not know today whether MS patients on medication are more susceptible to the virus. This study by the Columbia University MS Center in New York City aims to answer that question. In addition, we want to better understand the impact of the pandemic on your well-being and whether MS patients experience social distancing differently. To accomplish our study, we will compare the experience of healthy people and to that of people of MS, so we appreciate participation from both groups of individuals.

Do You Qualify?
Are you 18 years of age or older?YesNo
Do you live in the United States of America?YesNo
Philip De Jager, MD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Fatoumata Diallo
Phone: 212-305-1485